Neurocrine Biosciences, Inc. · NASDAQ:NBIX
Delaet Ingrid sold 2,261 Neurocrine Biosciences, Inc. shares (Form 4)
Traded May 29, 2026 · Filed Jun 2, 2026
On May 29, 2026, Delaet Ingrid (Chief Regulatory Officer) sold 2,261 Neurocrine Biosciences, Inc. shares at US$156.71 for US$354K under a trading plan, leaving 16,225 shares. Filed Jun 2, 2026 (Form 4).
- Sold
- 2,261 shares
- Price
- US$156.71
- Value
- US$354K
- Holding after
- 16,225 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Regulatory Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 29, 2026 | Common Stock | Option exercise | 2,261 | US$79.02 | 18,486 | Direct |
| May 29, 2026 | Common Stock | Sale | 2,261 | US$156.71 | 16,225 | Direct |
Source
Related
- Neurocrine Biosciences, Inc.
- Delaet Ingrid
- Neurocrine Biosciences, Inc. shareholders
- Form 4 · Delaet Ingrid · Sep 15, 2026
- Form 4 · Delaet Ingrid · Jul 13, 2026
- Form 4 · Delaet Ingrid · Jul 9, 2026
- Schedule 13G/A · JPMorgan Chase & Co · Oct 15, 2026
- Form 4 · Boyer David W. · Sep 15, 2026
- Form 4 · Abernethy Matt · Sep 15, 2026
- Form 4 · Gano Kyle · Sep 15, 2026
- Form 4 · Onyia Jude · Sep 15, 2026